时钟基因PER调控血压的研究进展

doi:10.16352/j.issn.1001-6325.2022.02.018

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (2): 311-315.doi: 10.16352/j.issn.1001-6325.2022.02.018

时钟基因PER调控血压的研究进展

计慧芳, 付阳, 董一飞^*

南昌大学第二附属医院心血管内科江西省分子医学重点实验室, 江西南昌 330006

收稿日期:2020-09-17 修回日期:2021-01-04 发布日期:2022-01-24
通讯作者: ^* yf_dong66@126.com
基金资助:
国家自然科学基金(81960088)

Advances in research on blood pressure regulation by clock gene PER

JI Hui-fang, FU Yang, DONG Yi-fei^*

Department of Cardiovascular Medicine,Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang 330006,China

Received:2020-09-17 Revised:2021-01-04 Published:2022-01-24
Contact: ^* yf_dong66@126.com

摘要/Abstract

摘要： 时钟基因的异常表达与血压昼夜节律紊乱以及高血压的发生发展密切相关。本文总结了时钟基因周期基因(PER)与血压昼夜节律的关系,在与血压调控相关的外周组织器官中PER的异常表达对血压的影响以及高血压时间疗法的研究进展。旨在为高血压的临床诊治和预后提供新思路。

关键词: PER, 血压昼夜节律, 高血压, 时间疗法

Abstract: The abnormal expression of clock genes is closely related to the circadian rhythm of blood pressure and to the occurrence and development of hypertension. This article summarizes the relationship between the clock gene period (PER) and the circadian rhythm of blood pressure, the influence of abnormal expression of PER in peripheral tissues and organs related to blood pressure regulation on blood pressure, and the research progress in the field of hypertension chronotherapy. The author hopes to provide new ideas for the clinical diagnosis, treatment and prognosis of hypertension.

Key words: PER, blood pressure circadian rhythm, hypertension, chronotherapy

中图分类号:

计慧芳, 付阳, 董一飞. 时钟基因PER调控血压的研究进展[J]. 基础医学与临床, 2022, 42(2): 311-315.

JI Hui-fang, FU Yang, DONG Yi-fei. Advances in research on blood pressure regulation by clock gene PER[J]. Basic & Clinical Medicine, 2022, 42(2): 311-315.

参考文献

[1]中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24: 24-56.
[2]Myung J, Schmal C, Hong S, et al. The choroid plexus is an important circadian clock component[J]. Nat Commun, 2018, 9: 1062. doi: 10.1038/s41467-018-03507-2.
[3]Kume K, Zylka MJ, Sriram S, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop[J]. Cell, 1999, 98: 193-205.
[4]Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator[J]. Cell, 2002, 110: 251-260.
[5]Sato TK, Panda S, Miraglia LJ, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock[J]. Neuron, 2004, 43: 527-537.
[6]Douma LG, Holzworth MR, Solocinski K, et al. Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice[J]. Am J Physiol Renal Physiol, 2018, 314: F1138-F1144.
[7]Herichova I, Mravec B, Stebelova K, et al. Rhythmic clock gene expression in heart, kidney and some brain nuclei involved in blood pressure control in hypertensive TGR(mREN-2)27 rats[J]. Mol Cell Biochem, 2007, 296: 25-34.
[8]Viswambharan H, Carvas JM, Antic V, et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function[J]. Circulation, 2007, 115: 2188-2195.
[9]Wang R, Xiao M, Zhang Y, et al. RNA-sequencing analysis reveals l-theanine regulating transcriptional rhythm alteration in vascular smooth muscle cells induced by dexamethasone[J]. J Agric Food Chem, 2019, 67: 5413-5422.
[10]Skrlec I, Milic J, Heffer M, et al. Genetic variations in circadian rhythm genes and susceptibility for myocardial infarction[J]. Genet Mol Biol,2018, 41: 403-409.
[11]Katary M, Abdel-Rahman AA. Alcohol suppresses cardiovascular diurnal variations in male normotensive rats: role of reduced PER2 expression and CYP2E1 hyperactivity in the heart[J]. Alcohol, 2020, 89: 27-36.
[12]Douma LG, Solocinski K, Holzworth MR, et al. Female C57BL/6J mice lacking the circadian clock protein PER1 are protected from nondipping hypertension[J]. Am J Physiol Regul Integr Comp Physiol, 2019, 316: R50-R58.
[13]Douma LG, Crislip GR, Cheng KY, et al. Knockout of the circadian clock protein PER1 results in sex-dependent alterations of ET-1 production in mice in response to a high-salt diet plus mineralocorticoid treatment[J]. Can J Physiol Pharmacol, 2020,98:579-586.
[14]Alli A, Yu L, Holzworth M, et al. Direct and indirect inhibition of the circadian clock protein Per1: effects on ENaC and blood pressure[J]. Am J Physiol Renal Physiol, 2019, 316: F807-F813.
[15]Tanaka S, Ueno T, Tsunemi A, et al. The adrenal gland circadian clock exhibits a distinct phase advance in spontaneously hypertensive rats[J]. Hypertens Res, 2019, 42: 165-173.
[16]Ivy JR, Jones NK, Costello HM, et al. Glucocorticoid receptor activation stimulates the sodium-chloride cotransporter and influences the diurnal rhythm of its phosphorylation[J]. Am J Physiol Renal Physiol,2019, 317: F1536-F1548.
[17]Rabinovich-Nikitin I, Lieberman B, Martino TA, et al. Circadian-regulated cell death in cardiovascular diseases[J]. Circulation, 2019, 139: 965-980.
[18]Yang K, Wang Y, Ding Y, et al. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats[J]. Chronobiol Int, 2019, 36: 1058-1071.
[19]Luan J, Yang K, Ding Y, et al. Valsartan-mediated chronotherapy in spontaneously hypertensive rats via targeting clock gene expression in vascular smooth muscle cells[J]. Arch Physiol Biochem, 2019,3: 1-11.
[20]Poulter NR, Savopoulos C, Anjum A, et al. Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure[J]. Hypertension, 2018, 72: 870-873.
[21]Hermida RC, Crespo JJ, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial[J]. Eur Heart J, 2019:ehz754. doi: 10.1093/eurheartj/ehz754.
[22]Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hyperten-sion. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)[J]. G Ital Cardiol (Rome), 2018, 19: 3S-73S.
[23]Umemura S, Arima H, Arima S, et al. The japanese society of hypertension guidelines for the management of hypertension (JSH 2019)[J]. Hypertens Res, 2019, 42: 1235-1481.
[24]Rabi DM, Mcbrien KA, Sapir-Pichhadze R, et al. Hypertension canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children[J]. Can J Cardiol, 2020, 36: 596-624.
[25]American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2019[J]. Diabetes Care,2019, 42: S103-S123.

时钟基因PER调控血压的研究进展

Advances in research on blood pressure regulation by clock gene PER

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	邹文兵, 王安仙, 曹政媛. 贵阳地区原发性高血压患者降压药物疗效相关基因的多态性[J]. 基础医学与临床, 2024, 44(7): 979-983.
[2]	张佳, 王艳丽, 宋晓丛, 王淑珍. 张家口市高血压视网膜病变患者情况调查及危险因素分析[J]. 基础医学与临床, 2024, 44(6): 853-857.
[3]	韩丽杰, 胡朝伟, 于华惠, 秦彦文. 血管生成素样蛋白8在心血管疾病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44(4): 544-547.
[4]	蒋晨晨, 崔泽, 潘利, 孙纪新, 何慧婧, 胡耀达, 单广良. 河北省汉族和满族成人高血压家族史与超重/肥胖对高血压发病的交互作用[J]. 基础医学与临床, 2023, 43(7): 1053-1059.
[5]	王春源, 边立立, 李肖肖. 北京月坛社区老年高血压患者抑郁情绪调查及危险因素分析[J]. 基础医学与临床, 2023, 43(5): 798-803.
[6]	王琴, 张晓艳, 刘雪婷, 李炳蔚, 李宏伟, 杨义力, 韩建群. 全杜仲胶囊对自发性高血压大鼠肠壁微血流灌注的影响[J]. 基础医学与临床, 2023, 43(3): 386-392.
[7]	王振花, 李潮生. 饮食作用的肠道菌群-免疫轴与高血压相关性的研究进展[J]. 基础医学与临床, 2022, 42(6): 983-987.
[8]	杜瑾, 申郁冰, 杨翠红, 陈雅丽, 姜晶梅. 新疆阿勒泰市哈萨克族不同职业人群高血压相关因素分析[J]. 基础医学与临床, 2022, 42(4): 577-582.
[9]	游慧, 康海军, 陈方, 李恒. 高血压视网膜病变患者外周血单个核细胞Notch1水平及其与血管内皮功能的相关性[J]. 基础医学与临床, 2022, 42(10): 1528-1532.
[10]	易达松, 袁善斌, 曾俊义, 赵健清, 丁露, 文通, 聂俊刚. 自发性高血压大鼠年龄相关性左心室肥厚的动态变化[J]. 基础医学与临床, 2022, 42(10): 1481-1486.
[11]	王书畅, 朱惠娟, 潘慧. 肢端肥大症与高血压[J]. 基础医学与临床, 2021, 41(9): 1366-1370.
[12]	李肖肖, 边立立, 董玉明, 李娟, 刘丹丹. 月坛社区高血压患者用药及血压控制情况调查[J]. 基础医学与临床, 2021, 41(1): 93-96.
[13]	刘宁, 张伟华. 糖尿病合并高血压加重血管病变的研究进展[J]. 基础医学与临床, 2020, 40(7): 990-994.
[14]	房星星陈冬梅沈燕沈良兰. 缬沙坦联合氨氯地平治疗高血压肾病的疗效评价[J]. , 2019, 39(12): 1756-1759.
[15]	李炳蔚苑晓晨张晓艳王冰李宏伟刘淑英修瑞娟. 血红素加氧酶-1上调自发性高血压大鼠肝脏MMP-2与MMP-9表达[J]. 基础医学与临床, 2013, 33(9): 1180-1185.